TopMarketGainers

Reversal trade in Mirati therapeutics.

Long
NASDAQ:MRTX   MIRATI THERAPEUTICS INC
AVERAGE ANALYSTS PRICE TARGET $109
AVERAGE ANALYSTS RECOMMENDATION OVERWEIGHT
P/R RATIO
SHORT INTEREST 12
COMPANY PROFILE
Mirati Therapeutics , Inc. is a clinical-stage oncology company, which engages in developing a pipeline of oncology products to treat genetic, immunological and epigenetic drivers of cancer in subsets of cancer patients. Its clinical pipeline consists of glesatinib, sitravatinib and mocetinostat. The company was founded on December 13, 1995 and is headquartered in San Diego, CA.


Do you want to GAIN an Edge on Wall Street?

1) Sign Up for Free @ http://www.TopMarketGainers.com

2) Follow our Telegram Channel @ https://t.me/TopMarketGainers

3) Join our LIVE CHAT on our Discord @ https://discord.gg/bGANmgy

Comments

Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter
Profile Profile Settings Account and Billing Referred friends Coins My Support Tickets Help Center Private Messages Chat Sign Out